Methods and Compositions for Assessing Patients with Preeclampsia-Related Conditions Using MicroRNA
AssigneeEwinger, Inc.
InventorsEdward E. WINGER, Jane REED
Life of this patent
Estimating the term…
Abstract
The invention is directed to methods and compositions for collecting a non-placental biological samples of cells and quantifying and comparing levels of expression of microRNAs to characterize a preeclampsia-related condition. The samples may be collected before or after an intervention or may be collected over a period of time. One of the samples may be a control sample. Patients may then be treated according to their response.
Claims22
A method for characterizing a preeclampsia-related condition in a subject comprising:
- collecting a first non-placental biological sample;
- extracting microRNA-comprising RNA from the first non-placental biological sample;
- quantifying at least one microRNA within the extracted RNA;
- and
- comparing the quantification of the at least one microRNA to a quantification of the at least one microRNA from a second, non-placental biological sample.
A diagnostic kit for characterizing a preeclampsia-related condition comprising a microarray including at least five microRNAs selected from the group consisting of hsa-miR-1, hsa-miR-1229, hsa-miR-1244, hsa-miR-1267, hsa-miR-132, hsa-miR-133b, hsa-miR-144-3p, hsa-miR-146a, hsa-miR-148a-3p, hsa-miR-155, hsa-miR-16, hsa-miR-181a, hsa-miR-193a-3p, hsa-miR-196a, hsa-miR-199a-5p, hsa-miR-199b-5p, hsa-miR-210, hsa-miR-219-5p, hsa-miR-221-5p, hsa-miR-223, hsa-miR-301a-3p, hsa-miR-30e-3p, hsa-miR-33a-5p, hsa-miR-340-5p, hsa-miR-424-5p, hsa-miR-513a-5p, hsa-miR-hsa-miR-575, hsa-miR-582-5p, hsa-miR-671-3p and hsa-miR-7-5p.
Dependencies are inferred from the claim text.